The electronic frailty index indicates mortality risk in end stage kidney disease patients on haemodialysis: retrospective survival analyses using linked data from two sources

电子衰弱指数可预测终末期肾病血液透析患者的死亡风险:基于来自两个来源的关联数据的回顾性生存分析

阅读:1

Abstract

BACKGROUND: Over the last 30 years, with increasing comorbidity and frailty among people with end-stage kidney disease, there is recognition that dialysis may carry little benefit in some patient groups. We examined the utility of the electronic frailty index (eFI), modelling the survival time of patients starting dialysis at a single renal unit in northern England, hypothesising this would give useful prognostic survival information. METHODS: Two datasets describing the same population of patients receiving dialysis over a 226-month period (2000-2019) at a single dialysis unit were used (n = 599 and 553 participants). One dataset was derived from primary care (linked to UK Renal Registry submissions) and the other from the UK Renal Registry (linked with primary care data to facilitate eFI calculation). Retrospective survival analysis was undertaken with hazard ratios for the impact of eFI and other covariates on survival. RESULTS: The frailty score at dialysis start has a strong effect on subsequent survival time using either the primary care-derived or UK Renal Registry dataset, but there were differences in overall survival and the relation between eFI score and survival between datasets. CONCLUSIONS: This represents the first study of eFI utility within tertiary renal care, demonstrating a strong association between frailty measured by eFI and survival time for patients on dialysis. However, significant differences between primary care-derived and UK Renal Registry-derived survival at different frailty scores were demonstrated. These differences indicate a need for greater understanding and analysis of large datasets before using them to discuss patient treatment choices, service planning and delivery.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。